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Abstract
Background: Shorter time to treatment is associated with lower mortality in acute coronary
syndromes (ACS). A previous (1994) survey showed substantial delays for acute myocardial
infarction (AMI) in Ireland. The present study compared current practice with 1994 and surveyed
acute coronary syndromes as a more complete contemporary evaluation of critical cardiac care
than assessing AMI alone.
Methods: Following ethics committee approval, all centres (N = 39) admitting acute cardiac
patients to intensive/coronary care unit provided information on 1365 episodes. A cross-sectional
survey design was employed.
Results: Since 1994, median hospital arrival to thrombolysis time was reduced by 41% (76 to 45
minutes). Thrombolysis was delivered more often in the emergency department in 2003 (48% vs
2%). Thrombolysis when delivered in the emergency department was achieved faster than
thrombolysis delivered in intensive/coronary care (35 mins v 60 mins; z = 5.62, p < .0001).
Suspected AMI patients who did not subsequently receive thrombolysis took longer to present to
hospital (5 h vs 2 h 34 mins; z = 7.33, p < .0001) and had longer transfer times to the intensive/
coronary care unit following arrival (2 h 17 mins vs 1 h 10 mins; z = 8.92, p < .0001). Fewer
confirmed AMI cases received thrombolysis in 2003 (43% vs 58%). There was an increase in
confirmed cases of AMI from 1994 (70% to 87%).
Conclusions:  Substantial improvements in time to thrombolysis have occurred since 1994,
probably relating to treatment provision in emergency departments. Patient delay pre-hospital is
still the principal impediment to effective treatment of ACS. A recent change of definition of AMI
may have precluded an exact comparison between 1994 and 2003 data.
Background
Ireland has one of the highest mortality rates from cardi-
ovascular disease in the European Union [1]. Acute coro-
nary syndrome (ACS) is a major portion of cardiovascular
diseases. ACS includes unstable angina and both persist-
ent-ST-segment elevation and non-ST segment elevation
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acute myocardial infarction (AMI) [2-4]. Thrombus for-
mation is the primary reason for myocardial infarction
[5]. This usually occurs after a complex interaction
between coronary atherosclerosis, plaque rupture and
platelet activation. Thrombolysis is an appropriate treat-
ment for thrombus formation in ST-elevation AMI and
when delivered in a 'timely' manner, preferably within 6
hours but including up to 12 hours after symptom onset
[6,7], can significantly reduce morbidity and mortality
from AMI. Each hour of time saved can lead to a decrease
of about 1.6 deaths per 1000 patients treated [7]. There-
fore, shortening of time to treatment for AMI patients is
an important life-saving goal for health services [6].
International guidelines, for example those from the
European Society of Cardiology [8,9] and the British
Heart Foundation [10], have proposed a 'call-to-needle'
time of 90 minutes for thrombolysis administration. The
National Service Framework (NSF) in the United King-
dom (UK) further reduced the recommended time in
2000 with a proposed 'call-to-needle' time of 60 minutes
[11]. Furthermore, eligible patients should be throm-
bolysed within 30 minutes of arrival at hospital [9]. In Ire-
land, the 1994 national census found a median time to
treatment of 4 hours 30 minutes [12]. This compares
unfavourably to more recently recorded median treat-
ment times in other countries, e.g. 2 hours 45 minutes in
the UK [13] or 2 hours 54 minutes in Switzerland [14].
Approximately 50% of AMI deaths in the community
occur within two hours from the onset of symptoms [15].
Early management of AMI patients with thrombolysis sig-
nificantly reduces morbidity and mortality [16]. Time to
treatment can be shortened by thrombolysing patients in
the emergency department prior to transfer to intensive/
coronary care. This strategy has lead to significant reduc-
tions in delay [17].
Since 1994, there has been no examination of time to
treatment and the extent to which international guide-
lines for treatment of AMI are being achieved in Ireland.
This study assessed the presentation and management of
a national cohort of suspected ACS patients admitted to
intensive/coronary care units (I/CCUs) in all 39 Republic
of Ireland hospitals providing such care. We decided to
extend the range of patients assessed from those with sus-
pected AMI (as was the case in previous surveys [12,18])
to all suspected ACS patients, to profile the pool of possi-
ble patients presenting from which testing determines eli-
gibility for reperfusion therapy. Differing proportions of
reperfusion-eligible patients over time or centre, along-
side the absolute number of patients presenting, may
influence the speed of management of eligible patients.
Also, some treatments for other ACS (e.g. unstable
angina) can be similar to treatment for AMI, depending
on the severity of the event [19] (e.g. angioplasty treat-
ment for unstable angina). Changes in the definition of
AMI in recent years have lead to an increase in the propor-
tion of diagnosed AMI patients and a decrease in the pro-
portion of patients diagnosed as having unstable angina
[20-22]. which may preclude exact comparison to previ-
ous findings. Where possible we compare data to results
from 1994.
Methods
Sample
All Irish centres admitting suspected ACS patients to I/
CCU (N = 39) agreed to participate following relevant eth-
ics approval [23]. Data collection was conducted from
January to October 2003. Four hospitals had not recruited
25 suspected AMI patients by the study cut-off date. Sus-
pected acute coronary syndrome (ACS) patients admitted
to I/CCU were recruited. Staff were provided with the con-
sensus definition of ACS as agreed in 2000 by the Joint
European Society of Cardiology/American College of Car-
diology Committee [4]. This definition uses enzyme (tro-
ponin) change as a marker of myocardial necrosis. The
survey was of suspected ACS and the main focus was on
how patients with suspected ACS are treated in the early
phase of their hospital admission. Therefore the admis-
sion diagnosis was used to categorise patients (e.g. if a
patient was admitted to I/CCU with a diagnosis of 'chest
pain – query AMI', they were listed as suspected AMI for
the purposes of this study; if patients were admitted with
suspected ACS or suspected unstable angina, they were
categorised as 'other ACS'). Data on successive admissions
were audited anonymously from hospital charts. Partici-
pating hospitals recruited all consecutive suspected ACS
patients, until 25 suspected cases of AMI had been admit-
ted to I/CCU. Data on a total of 1365 episodes were col-
lected (935 suspected AMI and 430 suspected other ACS
admitted contemporaneously). Data collected assessed
demographic details, clinical history, risk factors, presen-
tation and management profile. Eligible patients were
also approached to participate in a follow-up survey
(results to be reported elsewhere).
Analysis
Analysis was conducted on the data using STATA/SE 8.0.
Mann-Whitney U tests were used to test for significance
between treatment times, χ2 was used for categorical vari-
ables, and t-tests were used for continuous variables.
Results from 1994 are reported, but significance tests were
not conducted between 1994 and 2003 data (as raw data
from 1994 was unavailable). Total time to treatment was
defined as follows: symptom onset to reperfusion (throm-
bolysis or direct infarct angioplasty). Inpatient and other
hospital transfer times were not included in the analysis
for 1994 or 2003 samples.BMC Cardiovascular Disorders 2005, 5:5 http://www.biomedcentral.com/1471-2261/5/5
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Results
Baseline characteristics
The sample consisted of 1365 episodes, 935 suspected
AMI and 430 suspected other ACS patients. The gender
breakdown has been described elsewhere (manuscript
submitted for publication). The overall mean age was 64
years (std dev = 13; median = 65; range = 20–100 yrs).
Admission characteristics are shown in table 1.
The demographic profile of patients admitted for sus-
pected AMI in 2003 appears similar to those admitted in
1994. Other ACS patients differed from suspected AMI
patients in 2003 in the following aspects: they were
younger, less likely to be admitted by ambulance, more
likely to drive themselves to hospital, and had a higher
prevalence of previous ACS and coronary interventions.
Thrombolysis
Both location of, and speed of administration of throm-
bolysis have changed considerably in a positive direction
since 1994 (Figure 1). In 1994, 38% of suspected AMI and
58% of confirmed AMI patients received thrombolysis,
which occurred in I/CCU (96%), emergency department
(2%) or other location (2%). In 2003, 41% of suspected
AMIs and 44% of confirmed AMIs were thrombolysed in
I/CCU (48%), emergency department (48%) or other
location (4%). A further 4% of suspected AMIs received
direct infarct angioplasty.
Emergency department delivered thrombolysis occurred
in a significantly shorter time (median 35 minutes) than
I/CCU administered thrombolysis (median 60 minutes)
in 2003 (z = 5.62, p < .0001).
In 2003, 29% of those thrombolysed were treated within
90 minutes of calling for professional help. This rose to
42% and 62% within 2 and 3 hours respectively. On hos-
pital arrival, 35% of patients were thrombolysed within
30 minutes, rising to 60% and 74% within 60 and 90
minutes respectively. Thirty-six per cent of hospitals
thrombolysed 80% or more of patients in the emergency
department while 56% of hospitals thrombolysed over
50% of patients in the emergency department.
Time to treatment
Suspected AMI patients waited a similar length of time to
get to hospital from onset of symptoms in 2003 as 1994
(Table 2). Symptom onset to hospital arrival time was sig-
Table 1: Comparative demographic and admission profile in 1994 and 2003
Demographic 1994 (N = 950 
suspected AMI)
2003
Suspected AMI (N = 935) Suspected Other ACS (N = 430) Combined (N = 1365)
Mean age (years) (mean) (std dev) - 66 (13) 61*** (14) 64 (13)
Men 64 (12) 64 (13) 60*** (13) 63 (13)
Women 69 (11) 71 (13) 64*** (14) 69 (13)
Referral source (%)
Primary care physician 69 53 55 53
Self 24 39 33 38
Other 7 8 12 9
Admission mode to hospital (%)
Ambulance 46 48 38** 45
Car (passenger) 42 42 43 42
Car (driver) 8 6 12*** 8
Other 4 4 7 5
Distance from hospital at 
symptom onset
Median (range) miles 9 (0–165) 9 (0–80) 8 (0–150) 8 (0–150)
Previous CHD history (%)
AMI 24 16 31*** 21
Unstable angina 14 14 28*** 19
Coronary artery bypass graft 4 5 13*** 7
Percutaneous coronary intervention 2 6 18*** 10
(*p < .05, **p < .01, ***p < .001)BMC Cardiovascular Disorders 2005, 5:5 http://www.biomedcentral.com/1471-2261/5/5
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nificantly higher for patients admitted with suspected
other ACS in 2003 (3 h 35 mins vs 4 h 39 mins, z = 2.99,
p < .01).
Patients waited longer to be admitted to I/CCU in 2003,
but received thrombolysis more quickly (45 mins v 76
mins) after hospital arrival. This represents a 41%
decrease in time-to-thrombolysis since 1994. In 2003,
total time to treatment for suspected AMI patients who
received reperfusion was 4 hours 00 mins.
Patients with suspected AMI who were subsequently
thrombolysed (thrombolysed AMIs) presented to
hospital (2 h 34 mins vs 5 h, z = 7.33, p < 0.0001) and had
a faster I/CCU transfer time (1 h 10 mins vs 2 h 17 mins,
z = 8.92, p < 0.0001) than suspected AMI patients who
Thrombolysis administration locations and treatment times in 1994 and 2003 Figure 1
Thrombolysis administration locations and treatment times in 1994 and 2003
Table 2: Median overall time to treatment for all patients in 1994 and 2003
Treatment times 1994 Suspected 
AMI (n = 950)
2003
Thrombolysed AMIs 
(n = 382)
Suspected AMI – 
non-thrombolysed 
(n = 553)
All suspected 
AMI (n = 935)
Suspected other 
ACS (n = 430)
Total
(n = 1365)
Symptom onset to hospital 3 h 30 mins 2 h 34 mins 5 h 00 mins*** 3 h 35 mins 4 h 39 mins** 3 h 56 mins
Call-to-thrombolysis Unavailable 2 h 20 mins - 2 h 20 mins - -
Hospital arrival to I/CCU 55 mins 1 h 10 mins 2 h 17 mins*** 1 h 40 mins 2 h 43 mins*** 1 h 55 mins
Hospital arrival to 
thrombolysis
76 mins 45 mins - 45 mins - -
I/CCU admission to 
thrombolysis
25 mins 20 mins - 20 mins - -
(*p < .05, **p < .01, ***p < .001)BMC Cardiovascular Disorders 2005, 5:5 http://www.biomedcentral.com/1471-2261/5/5
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were not thrombolysed (non-thrombolysed AMIs). Sus-
pected other ACS patients also waited significantly longer
than non-thrombolysed AMIs for hospital transfer to I/
CCU (2 h 43 mins vs 2 h 17 mins; z = 2.128, p < 0.05).
In 1994, treatment times for patients referred by primary
care physicians were significantly longer than those who
self-referred (symptom onset to hospital arrival: primary
care physician-referred 4 h 15 mins, self-referred 2 h 05
mins, p < 0.001). In 2003, primary care physician-referred
suspected AMI patients also had a significantly longer pre-
hospital delay (5 h vs 2 h 28 mins, z = 7.9, p < 0.001).
For suspected AMI patients, a previous experience of AMI
made no difference to hospital presentation time (3 h vs
3 h 45 mins, z = 1.2, p > 0.05). There were no gender dif-
ferences in pre-hospital delay time (3 h 53 mins for men
vs 3 h 14 mins for women, z = 0.63, p > 0.05), or hospital
arrival to thrombolysis time (45 mins for men vs 50 mins
for women, z = 1.43, p > 0.05) for suspected AMI patients
in 2003.
Discharge
For suspected AMI patients, there was an increase in those
patients diagnosed with myocardial infarction of 21%
from 1994 to 2003, and a 10% reduction in the diagnosis
of unstable angina (Table 3).
In 2003, thrombolysed AMIs were more likely to be dis-
charged as having myocardial infarction than non-throm-
bolysed AMIs, but were less likely to receive a discharge
diagnosis of unstable angina, other cardiac or non-cardiac
diagnoses. All suspected AMI patients in 2003 were more
likely to be discharged as having had myocardial infarc-
tion and were more likely to die in hospital than sus-
pected other ACS patients, but were less likely to have
discharge diagnoses of unstable angina, other cardiac or
non cardiac.
Discussion
The present survey outlines the current presentation and
management of ACS in Ireland. This study built on the
previous research conducted in 1994, but also expanded
its findings beyond suspected AMI patients to all sus-
pected ACS patients. Pre-hospital patient delay remains
stable and substantial, while a considerable reduction
(41%) in time to thrombolysis from hospital admission
has occurred since 1994. This can probably be attributed
in large part to the relocation of thrombolytic administra-
tion to the emergency department, thereby reducing the
'door-to-needle' times in 2003. Similarly, treatment of
AMI patients in emergency departments prior to transfer
to I/CCU may account for longer I/CCU transfer times in
2003.
Significant progress has been made in the treatment of
AMI patients who receive thrombolysis, which has yielded
faster 'door-to-needle' times. Suspected AMI patients who
received thrombolysis in the 2003 sample were treated
more quickly than 1994 (median 45 mins v 76 mins).
The transfer of thrombolytic administration from the I/
CCU (96% in 1994) to the emergency department (48%
in 2003, with 48% administered in I/CCU) is probably
the main reason for the decreased time to treatment for
thrombolysed patients. The present survey found, for
instance, that 56% of hospitals thrombolysed over half of
their patients in the emergency department. It is not clear,
however, that an additional shift of thrombolysis to the
emergency department in the remaining hospitals would
also result in a further reduction of 'door-to-needle' time.
This is because some hospitals already adopt a 'fast-track'
policy, where chest pain patients are admitted directly to
CCU, bypassing emergency department assessment.
Adopting a strategy of emergency department thromboly-
sis may have little or no effect in these cases.
Table 3: I/CCU discharge diagnoses and hospital mortality (%)
Discharge diagnosis 1994 Census 
(suspected AMI) 
%
CCU 2003 Survey
Thrombolysed AMIs 
(n = 382)
Suspected AMI – non-
thrombolysed (n = 553)
Suspected AMI Suspected 
Other ACS
Total
Myocardial infarction 70 97 86*** 91 19*** 68
Unstable angina 14 <1 6*** 44 7 * * * 1 7
Other cardiac 9 51 1 * *93 2 * * * 1 6
Non cardiac 7 15 * *31 7 * * * 8
Mortality 11 91 0 10 1*** 7
Patients may have more than one diagnosis
(*p < .05, **p < .01, ***p < .001)BMC Cardiovascular Disorders 2005, 5:5 http://www.biomedcentral.com/1471-2261/5/5
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Nonetheless, only 35% of patients received thrombolysis
within 30 mins of hospital arrival, which compares unfa-
vourably to other surveys (e.g. in England and Wales in
2003, the MINAP study found that over 80% of patients
were thrombolysed within 30 mins of hospital arrival
[24]). These comparisons must be interpreted with some
caution however, since MINAP does not count cases
which have a component of extra delay due to clinical rea-
sons (i.e. patients presenting with contraindications to
thrombolysis), and reports on all eligible STEMI cases
treated within 30 mins of hospital arrival. Our analysis
included all patients who eventually received thromboly-
sis, even those patients who developed ST-elevation some
time after hospital arrival. While our results may not be
completely comparable to other similar surveys, the over-
all message that thrombolysis is unsatisfactory both in
absolute and comparative terms is clear.
Substantial pre-hospital and in-hospital delays were seen
for non-thrombolysed AMIs. Suspected AMI patients who
did not receive thrombolysis waited significantly longer
for transfer to I/CCU than those who received thrombol-
ysis. Indeed, this group of AMIs had comparable times to
patients with suspected other ACS. These patients pre-
sented to hospital more slowly than thrombolysed AMIs.
This may indicate the less severe symptoms of unstable
angina and non-ST-elevation myocardial infarction. Also,
recent changes in AMI definition have lead to increases in
proportions of diagnosed AMI patients and decreases in
proportions of patients diagnosed with unstable angina
[20-22]. These changes probably preclude exact compari-
son with 1994 findings. Adding credence to this hypothe-
sis was the large change in discharge diagnoses.
Considering suspected AMIs, the proportion of patients
diagnosed with myocardial infarction increased by 21%
from 1994 to 2003, with a corresponding 10% reduction
in unstable angina diagnoses. The reduction in 'non car-
diac' discharges for suspected AMI patients (7% in 1994 to
3% in 2003), may be partially attributed to definition
change [21]. Finally, the 14% decrease in thrombolysed
confirmed AMIs may also be attributed to the definition
change, with a larger portion of AMI patients being ineli-
gible for thrombolysis in 2003.
Suspected AMI patients who did not receive thrombolysis
took significantly longer from hospital arrival to arrive in
I/CCU than did patients who received thrombolysis. Sus-
pected other ACS patients presented to hospital in time
frames similar to suspected AMI patients who did not
receive thrombolysis, but were not admitted to I/CCU as
quickly. The development of chest pain assessment units
and other similar units (e.g. medical admission units),
which involve the initial screening of chest pain patients
to determine whether the pain is cardiac in origin prior to
transfer to I/CCU, may have skewed the data in the cur-
rent survey. A typical scenario may be that a patient cur-
rently arrives at hospital, without ST-elevation when
assessed by ECG, and is assessed for some time in the
chest pain assessment unit to either 'rule-in' or 'rule-out'
ACS. In the past, such patients may have been admitted
directly to I/CCU. In addition, these findings may reflect
the triaging of patients in the emergency department,
where patients labelled as suspected AMI were treated
more quickly than those labelled as suspected other ACS.
Patients can be triaged into groups reflecting the necessity
for immediate treatment. Non-ST-elevation myocardial
infarction and unstable angina patients may be detained
for observation in the emergency department. It might
also be that pressure for I/CCU bed places is more quickly
resolved for the more acute ST-elevation AMI patients.
However, further prospective observational research on
this aspect of care is required.
Patient delay prior to hospital arrival is still the biggest
impediment to improving treatment times for AMI and
other ACS. Patients who were referred by primary care
physicians had a significantly longer time to treatment
than those who self-referred in both 2003 and 1994.
Clearly, in the present system, although substantial
improvements have been made since the mid-1990s, a
'call-to-treatment' standard of 90 minutes is not currently
being met. The present survey found that 29% of patients
were thrombolysed within 90 minutes of calling for pro-
fessional help. Future research and resources need to focus
on a reduction in pre-hospital delay factors by the services
and professional groups concerned. A number of psycho-
logical studies have provided detailed examination of
patient contributions to delayed help-seeking for AMI
[25-27]. These highlight possibilities for intervention to
reduce symptom onset to help-seeking times but caution
against a simplistic public education campaign approach.
Since general public advertising/education campaigns
have little efficacy [25,26,28] and even a previous experi-
ence of AMI has no effect on pre-hospital call for assist-
ance times, sophisticated strategies are needed to address
this problem.
As regards reducing health services delay, one method is
to authorise health professionals in the pre-hospital
setting to administer thrombolysis. Ambulance personnel
and primary care physicians are the two most obvious
choices. The administration of thrombolysis by ambu-
lance personnel has been shown to reduce time to treat-
ment [29]. A recently completed study on thrombolysis
administered by primary care physicians showed the prac-
ticalities of this approach in an Irish setting [30]. In the
hospital setting, involving nurses in decision-making
processes for thrombolysis has been shown to be effective
in reducing treatment times [31,32]. The provision ofBMC Cardiovascular Disorders 2005, 5:5 http://www.biomedcentral.com/1471-2261/5/5
Page 7 of 8
(page number not for citation purposes)
more mobile coronary care units may also reduce delay
times in rural areas [33].
The present study has highlighted the need for a national
prospective registry of ACS. The value of such registries
has been shown in other countries. For example, registries
increase the use of appropriate reperfusion therapy, but to
ensure this practice continues they need to be ongoing
[34]. In the UK, MINAP [35] has contributed to an
increase in the numbers of patients thrombolysed within
recommended timescales. For example, following the
publication of the NSF guidelines on CHD in 2000 [11],
the proportion of patients receiving thrombolysis within
30 minutes of hospital arrival more than doubled (79% in
2002, compared with 38% pre-2000) [36]. Registries can
also underscore the extent of adherence to international
guidelines. The current Irish data highlight progress in
some areas over a nine-year period but indicate that
improvements need to occur in other aspects. A national
registry can provide the continuous feedback needed to
keep a focus on areas for improvement. The monitoring of
guideline adherence should even be considered a part of
optimal practice procedures [37].
Conclusions
Significant progress in some aspects (e.g. time to throm-
bolysis) of care for suspected ACS has occurred, but there
is still scope for improvement. A necessary goal is to
increase the proportions of patients seen within the rec-
ommended time. Other aspects of ACS care also now
require attention. Patient delay pre-hospital should
remain the main focus of future research. The implemen-
tation of a national registry would allow resources to be
focused on these aspects and facilitate routine health care
monitoring.
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